Mitochondrial inhibition as a novel therapeutic approach in drug-resistant cancer [electronic resource] / Dieter A. Wolf.
Material type:
FilmSeries: Henry Stewart talksBiomedical & life sciences collection: Publisher: London : Henry Stewart Talks, 2017Description: 1 online resource (1 streaming video file (31 min.) : color, sound)Subject(s): Antineoplastic agents | Drug resistance in cancer cells | Prostate -- Cancer -- Chemotherapy | Antineoplastic Agents -- pharmacology | Antineoplastic Agents -- therapeutic use | Down-Regulation -- drug effects | Drug Resistance, Neoplasm | Mitochondria -- drug effects | Mitochondria -- metabolism | Oxidative Phosphorylation -- drug effects | Prostatic Neoplasms -- drug therapy | Prostatic Neoplasms -- metabolism | Prostatic Neoplasms -- pathology | Receptors, Androgen | S-Phase Kinase-Associated ProteinsOnline resources: Click here to access online Animated audio-visual presentation with synchronized narration.
Title from title frames.
Contents: Drug resistance in prostate cancer -- Role of androgen receptor in prostate cancer -- Difficulties in finding new prostate cancer drug targets -- Rational behind screening for p27 downregulators -- Potential for OXPHOS inhibitors in cancer therapy -- SMIP004: p27 downregulator and potential drug.
Access restricted to subscribers.
Mode of access: World Wide Web.